MARKET

ALKS

ALKS

Alkermes Plc
NASDAQ
28.06
-0.11
-0.39%
After Hours: 28.06 0 0.00% 18:25 12/16 EST
OPEN
28.10
PREV CLOSE
28.17
HIGH
28.27
LOW
27.53
VOLUME
1.70M
TURNOVER
--
52 WEEK HIGH
36.45
52 WEEK LOW
25.17
MARKET CAP
4.63B
P/E (TTM)
13.87
1D
5D
1M
3M
1Y
5Y
1D
Tracking Baker Brothers Portfolio - Q3 2025 Update
Seeking Alpha · 15h ago
Weekly Report: what happened at ALKS last week (1208-1212)?
Weekly Report · 1d ago
Healthcare Dashboard For December And Focus On PJP
Seeking Alpha · 2d ago
HSR Waiting Period Expires for Avadel Pharmaceuticals Acquisition by Alkermes
Reuters · 12/09 21:16
Alkermes (ALKS) Gets a Hold from Bank of America Securities
TipRanks · 12/09 12:06
Weekly Report: what happened at ALKS last week (1201-1205)?
Weekly Report · 12/08 10:22
Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson Reports Disposal of Common Shares
Reuters · 12/05 21:22
Alkermes To Acquire Avadel Pharmaceuticals In Shareholder Scheme, Sends Proposal To Equity And Employee Share Purchase Plan Holders
Benzinga · 12/05 21:03
More
About ALKS
Alkermes plc is Ireland-based biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.

Webull offers Alkermes Plc stock information, including NASDAQ: ALKS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALKS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALKS stock methods without spending real money on the virtual paper trading platform.